Development of an amplified luminescent proximity homogeneous assay for quantitative determination of hepatitis B surface antigen in human serum

The novel AlphaLISA developed in this study has shorter incubation time and easier protocol than the ones of conventional ELISA. It could be used for the clinical determination of HBsAg in human serum. We established a platform for further development of other biomarkers.